Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076043
Company: TARO
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TERCONAZOLE TERCONAZOLE 0.4% CREAM;VAGINAL Prescription AB No Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/19/2005 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/20/2015 SUPPL-9 Labeling-Package Insert

Label is not available on this site.

08/20/2015 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

TERCONAZOLE

CREAM;VAGINAL; 0.4%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
TERCONAZOLE TERCONAZOLE 0.4% CREAM;VAGINAL Prescription No AB 076712 FOUGERA PHARMS
TERCONAZOLE TERCONAZOLE 0.4% CREAM;VAGINAL Prescription No AB 076043 TARO

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English